One quarter of prescription drugs in Canada may be in short supply
New research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read MoreAugust 28, 2020
Data and research that provides insight into the economics of health policies and practices is vital to help governments and policymakers make decisions about spending while balancing tradeoffs. CHÉOS investigators are leaders in this field. Their work has been instrumental in informing budgets, health care policies, and guidelines at all levels of government.
New research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read More
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read More
In recognition of World Hepatitis Day on July 28, CHÉOS Scientist Dr. Naveed Janjua discusses the BC Hepatitis Testers Cohort
Read More
As we enter into another exciting year of improving health outcomes for BC and beyond, we're reflecting on some of the CHÉOS research from the past year.
Read More
As Program Head of Health Services and Outcomes at CHÉOS, Dr. Jason Sutherland studies approaches to allocating funding as a way to improve value from health care
Read More
CHÉOS Scientists Dr. Aslam Anis and Dr. Wei Zhang conducted a cost-effectiveness analysis comparing three Down syndrome screening techniques, published this week in PLoS One
Read More